VC

Vivo Capital Portfolio holdings

AUM $977M
This Quarter Return
+2.16%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
AUM
$996M
AUM Growth
+$996M
Cap. Flow
-$258M
Cap. Flow %
-25.87%
Top 10 Hldgs %
67.37%
Holding
55
New
1
Increased
2
Reduced
8
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BLU
26
DELISTED
BELLUS Health Inc.
BLU
$9.4M 0.94%
1,017,152
VERA icon
27
Vera Therapeutics
VERA
$1.47B
$9.07M 0.91%
666,666
BOLT icon
28
Bolt Biotherapeutics
BOLT
$9.29M
$7.9M 0.79%
3,871,291
IOVA icon
29
Iovance Biotherapeutics
IOVA
$800M
$7.23M 0.73%
655,057
AVDL
30
Avadel Pharmaceuticals
AVDL
$1.42B
$7.17M 0.72%
2,937,093
OLMA icon
31
Olema Pharmaceuticals
OLMA
$432M
$6.88M 0.69%
1,689,515
DSGN icon
32
Design Therapeutics
DSGN
$340M
$6.67M 0.67%
476,589
TERN icon
33
Terns Pharmaceuticals
TERN
$651M
$6.63M 0.67%
2,675,133
WHWK
34
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$6.28M 0.63%
509,572
-262,844
-34% -$3.24M
CMPX icon
35
Compass Therapeutics
CMPX
$466M
$5.3M 0.53%
2,000,000
GRCL
36
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$5.29M 0.53%
961,359
UTRS
37
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$5.21M 0.52%
2,215,667
STSA
38
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$5.1M 0.51%
1,232,394
ARWR icon
39
Arrowhead Research
ARWR
$3.84B
$4.84M 0.49%
137,411
ALGS icon
40
Aligos Therapeutics
ALGS
$75.1M
$4.29M 0.43%
3,547,030
CDXS icon
41
Codexis
CDXS
$218M
$4.06M 0.41%
388,144
DYN icon
42
Dyne Therapeutics
DYN
$1.92B
$3.97M 0.4%
577,642
SERA icon
43
Sera Prognostics
SERA
$129M
$3.04M 0.31%
1,856,011
RZLT icon
44
Rezolute
RZLT
$628M
$1.58M 0.16%
+489,473
New +$1.58M
ZYME icon
45
Zymeworks
ZYME
$1.07B
$1.52M 0.15%
286,064
ASLN
46
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.41M 0.14%
2,840,909
QTTB icon
47
Q32 Bio
QTTB
$20.9M
$729K 0.07%
370,068
-483,075
-57% -$952K
DTIL icon
48
Precision BioSciences
DTIL
$59.5M
$224K 0.02%
140,255
MTCR
49
DELISTED
Metacrine, Inc. Common Stock
MTCR
$73K 0.01%
146,426
ELEV
50
DELISTED
Elevation Oncology
ELEV
-496,844
Closed -$1.25M